Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ventilation in chronic ventilatory failure

João Carlos Winck, Michele Vitacca, António Morais, Luca Barbano, Roberto Porta, Armando Teixeira-Pinto, Nicolino Ambrosino

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Study objectives: To compare the tolerance and physiologic effects of a 5-night treatment with either nasal proportional assist ventilation (PAV) or pressure support ventilation (PSV) in patients with chronic ventilatory failure. Design: Cross-over, randomized, controlled study. Setting: Rehabilitation units of pneumology department. Patients or participants: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline PaCO 2, 55.1 mm Hg) were studied. Interventions: In a cross-over study, nasal PAV and PSV set at the patient's comfort were randomly applied during 5 consecutive nights (with a 2-night washout period). Measurements and results: Continuous nocturnal pulse oximetric saturation (SpO 2) and arterial blood gas results at wake-up were evaluated at baseline during spontaneous breathing and on the fifth day of ventilatory support. Dyspnea, sleep quality, adaptation, and comfort at inspiration and expiration by visual analog scale (VAS) were evaluated every day as well as a side effects score. On the fifth day, there were no significant differences in daytime PaCO 2 (median PAV, 53.3 mm Hg; median PSV, 50.2; p = 0.168). Mean nocturnal SpO 2 improved significantly with both PAV and PSV without any significant differences between modes (baseline median, 92%; PAV median, 94.5%; PSV median, 95%). The percentage of the study night spent <90% SpO 2 (T90) was slightly but significantly higher with PAV than with PSV (median PAV T90, 4%; median PSV T90, 2%; p = 0.049). The VAS symptom score was similar at day 5 between modes; however, nasal and oral dryness were lower (p = 0.05) and alarm noise was higher (p = 0.037) with PAV. Conclusions: After 5 days of treatment, both modes had similar tolerance, and were equally effective in reducing daytime hypercapnia and improving nocturnal saturation and symptoms. However, PAV induced less nasal and oral dryness but was associated with higher alarm noise.

Original languageEnglish
Pages (from-to)382-388
Number of pages7
JournalChest
Volume126
Issue number2
DOIs
Publication statusPublished - Aug 2004

Fingerprint

Interactive Ventilatory Support
Masks
Ventilation
Pressure
Nose
Xerostomia
Hypercapnia
Visual Analog Scale
Cross-Over Studies
Noise
Thoracic Diseases
Pulmonary Medicine
Dyspnea
Chronic Obstructive Pulmonary Disease
Pulse
Sleep
Respiration
Rehabilitation
Gases

Keywords

  • Chronic ventilatory failure
  • COPD
  • Noninvasive mechanical ventilation
  • Pressure support ventilation
  • Proportional assist ventilation
  • Restrictive disorders

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ventilation in chronic ventilatory failure. / Winck, João Carlos; Vitacca, Michele; Morais, António; Barbano, Luca; Porta, Roberto; Teixeira-Pinto, Armando; Ambrosino, Nicolino.

In: Chest, Vol. 126, No. 2, 08.2004, p. 382-388.

Research output: Contribution to journalArticle

Winck, João Carlos ; Vitacca, Michele ; Morais, António ; Barbano, Luca ; Porta, Roberto ; Teixeira-Pinto, Armando ; Ambrosino, Nicolino. / Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ventilation in chronic ventilatory failure. In: Chest. 2004 ; Vol. 126, No. 2. pp. 382-388.
@article{c473a87a7a7a4423a9acf41098e0868f,
title = "Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ventilation in chronic ventilatory failure",
abstract = "Study objectives: To compare the tolerance and physiologic effects of a 5-night treatment with either nasal proportional assist ventilation (PAV) or pressure support ventilation (PSV) in patients with chronic ventilatory failure. Design: Cross-over, randomized, controlled study. Setting: Rehabilitation units of pneumology department. Patients or participants: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline PaCO 2, 55.1 mm Hg) were studied. Interventions: In a cross-over study, nasal PAV and PSV set at the patient's comfort were randomly applied during 5 consecutive nights (with a 2-night washout period). Measurements and results: Continuous nocturnal pulse oximetric saturation (SpO 2) and arterial blood gas results at wake-up were evaluated at baseline during spontaneous breathing and on the fifth day of ventilatory support. Dyspnea, sleep quality, adaptation, and comfort at inspiration and expiration by visual analog scale (VAS) were evaluated every day as well as a side effects score. On the fifth day, there were no significant differences in daytime PaCO 2 (median PAV, 53.3 mm Hg; median PSV, 50.2; p = 0.168). Mean nocturnal SpO 2 improved significantly with both PAV and PSV without any significant differences between modes (baseline median, 92{\%}; PAV median, 94.5{\%}; PSV median, 95{\%}). The percentage of the study night spent <90{\%} SpO 2 (T90) was slightly but significantly higher with PAV than with PSV (median PAV T90, 4{\%}; median PSV T90, 2{\%}; p = 0.049). The VAS symptom score was similar at day 5 between modes; however, nasal and oral dryness were lower (p = 0.05) and alarm noise was higher (p = 0.037) with PAV. Conclusions: After 5 days of treatment, both modes had similar tolerance, and were equally effective in reducing daytime hypercapnia and improving nocturnal saturation and symptoms. However, PAV induced less nasal and oral dryness but was associated with higher alarm noise.",
keywords = "Chronic ventilatory failure, COPD, Noninvasive mechanical ventilation, Pressure support ventilation, Proportional assist ventilation, Restrictive disorders",
author = "Winck, {Jo{\~a}o Carlos} and Michele Vitacca and Ant{\'o}nio Morais and Luca Barbano and Roberto Porta and Armando Teixeira-Pinto and Nicolino Ambrosino",
year = "2004",
month = "8",
doi = "10.1378/chest.126.2.382",
language = "English",
volume = "126",
pages = "382--388",
journal = "Chest",
issn = "0012-3692",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ventilation in chronic ventilatory failure

AU - Winck, João Carlos

AU - Vitacca, Michele

AU - Morais, António

AU - Barbano, Luca

AU - Porta, Roberto

AU - Teixeira-Pinto, Armando

AU - Ambrosino, Nicolino

PY - 2004/8

Y1 - 2004/8

N2 - Study objectives: To compare the tolerance and physiologic effects of a 5-night treatment with either nasal proportional assist ventilation (PAV) or pressure support ventilation (PSV) in patients with chronic ventilatory failure. Design: Cross-over, randomized, controlled study. Setting: Rehabilitation units of pneumology department. Patients or participants: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline PaCO 2, 55.1 mm Hg) were studied. Interventions: In a cross-over study, nasal PAV and PSV set at the patient's comfort were randomly applied during 5 consecutive nights (with a 2-night washout period). Measurements and results: Continuous nocturnal pulse oximetric saturation (SpO 2) and arterial blood gas results at wake-up were evaluated at baseline during spontaneous breathing and on the fifth day of ventilatory support. Dyspnea, sleep quality, adaptation, and comfort at inspiration and expiration by visual analog scale (VAS) were evaluated every day as well as a side effects score. On the fifth day, there were no significant differences in daytime PaCO 2 (median PAV, 53.3 mm Hg; median PSV, 50.2; p = 0.168). Mean nocturnal SpO 2 improved significantly with both PAV and PSV without any significant differences between modes (baseline median, 92%; PAV median, 94.5%; PSV median, 95%). The percentage of the study night spent <90% SpO 2 (T90) was slightly but significantly higher with PAV than with PSV (median PAV T90, 4%; median PSV T90, 2%; p = 0.049). The VAS symptom score was similar at day 5 between modes; however, nasal and oral dryness were lower (p = 0.05) and alarm noise was higher (p = 0.037) with PAV. Conclusions: After 5 days of treatment, both modes had similar tolerance, and were equally effective in reducing daytime hypercapnia and improving nocturnal saturation and symptoms. However, PAV induced less nasal and oral dryness but was associated with higher alarm noise.

AB - Study objectives: To compare the tolerance and physiologic effects of a 5-night treatment with either nasal proportional assist ventilation (PAV) or pressure support ventilation (PSV) in patients with chronic ventilatory failure. Design: Cross-over, randomized, controlled study. Setting: Rehabilitation units of pneumology department. Patients or participants: Four patients with COPD and 10 patients with restrictive thoracic diseases with chronic hypercapnia (median baseline PaCO 2, 55.1 mm Hg) were studied. Interventions: In a cross-over study, nasal PAV and PSV set at the patient's comfort were randomly applied during 5 consecutive nights (with a 2-night washout period). Measurements and results: Continuous nocturnal pulse oximetric saturation (SpO 2) and arterial blood gas results at wake-up were evaluated at baseline during spontaneous breathing and on the fifth day of ventilatory support. Dyspnea, sleep quality, adaptation, and comfort at inspiration and expiration by visual analog scale (VAS) were evaluated every day as well as a side effects score. On the fifth day, there were no significant differences in daytime PaCO 2 (median PAV, 53.3 mm Hg; median PSV, 50.2; p = 0.168). Mean nocturnal SpO 2 improved significantly with both PAV and PSV without any significant differences between modes (baseline median, 92%; PAV median, 94.5%; PSV median, 95%). The percentage of the study night spent <90% SpO 2 (T90) was slightly but significantly higher with PAV than with PSV (median PAV T90, 4%; median PSV T90, 2%; p = 0.049). The VAS symptom score was similar at day 5 between modes; however, nasal and oral dryness were lower (p = 0.05) and alarm noise was higher (p = 0.037) with PAV. Conclusions: After 5 days of treatment, both modes had similar tolerance, and were equally effective in reducing daytime hypercapnia and improving nocturnal saturation and symptoms. However, PAV induced less nasal and oral dryness but was associated with higher alarm noise.

KW - Chronic ventilatory failure

KW - COPD

KW - Noninvasive mechanical ventilation

KW - Pressure support ventilation

KW - Proportional assist ventilation

KW - Restrictive disorders

UR - http://www.scopus.com/inward/record.url?scp=4143120052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143120052&partnerID=8YFLogxK

U2 - 10.1378/chest.126.2.382

DO - 10.1378/chest.126.2.382

M3 - Article

VL - 126

SP - 382

EP - 388

JO - Chest

JF - Chest

SN - 0012-3692

IS - 2

ER -